These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Apomorphine and erectile dysfunction]. Tan DQ; Yao Y; Zhang J Zhonghua Nan Ke Xue; 2007 Sep; 13(9):818-21. PubMed ID: 17929561 [TBL] [Abstract][Full Text] [Related]
13. Safety and tolerability of apomorphine SL (Uprima). Bukofzer S; Livesey N Int J Impot Res; 2001 Aug; 13 Suppl 3():S40-4. PubMed ID: 11477491 [TBL] [Abstract][Full Text] [Related]
14. [Dopamine receptor stimulants in the treatment of alcoholism]. Anokhina IP; Ivanets NN; Reshchikova EV; Nebarakova TP Sov Med; 1988; (8):93-5. PubMed ID: 2904705 [No Abstract] [Full Text] [Related]
15. [Hypertension and impotence. Which potency drug is the most appropriate here?]. Köhn FM MMW Fortschr Med; 2002 Mar; 144(10):12-3. PubMed ID: 11928255 [No Abstract] [Full Text] [Related]
16. A successful treatment of buprenorphine withdrawal with the dopamine receptor agonist pramipexole. Makhinson M; Gomez-Makhinson J Am J Addict; 2014; 23(5):475-7. PubMed ID: 24628996 [TBL] [Abstract][Full Text] [Related]
17. [Therapy of withdrawal symptoms in "fixers". (Drug abuse of adolescents by intravenous injection)]. Amitai M; Dickhaut HH; Hasenknopf P Nervenarzt; 1972 Mar; 43(3):157-60. PubMed ID: 5023740 [No Abstract] [Full Text] [Related]
19. Effects of terguride, ropinirole, and acetyl-L-carnitine on methamphetamine withdrawal in the rat. Hoefer ME; Voskanian SJ; Koob GF; Pulvirenti L Pharmacol Biochem Behav; 2006 Mar; 83(3):403-9. PubMed ID: 16647107 [TBL] [Abstract][Full Text] [Related]
20. Fat necrosis and subcutaneous abscesses due to apomorphine. García-Zamora E; Elosua-González M; Floristán-Muruzábal U Med Clin (Barc); 2018 Oct; 151(7):294-295. PubMed ID: 29241872 [No Abstract] [Full Text] [Related] [Next] [New Search]